| Jewish Home And Care Center | |
| 1414 N Prospect Ave, Milwaukee, Wisconsin 53202 | |
| (414) 276-2627 | |
| Name | Jewish Home And Care Center |
|---|---|
| Location | 1414 N Prospect Ave, Milwaukee, Wisconsin |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 136 |
| Occupancy Rate | 64.85% |
| Medicare ID (CCN) | 525172 |
| Legal Business Name | Jewish Home And Care Center, Inc |
| Ownership Type | Non Profit - Corporation |
| NPI Number | 1437525235 |
| Address | 1414 N Prospect Ave, Milwaukee, WI 53202 |
| Phone Number | 414-277-8854 |
News Archive
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.
The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
› Verified 2 days ago
| NPI Number | 1477620516 |
| Organization Name | JEWISH HOME AND CARE CENTER, INC |
| Doing Business As | JEWISH HOME AND CARE CENTER |
| Address | 1414 N Prospect Ave, Milwaukee, WI 53202 |
| Phone Number | 414-276-2627 |
News Archive
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.
The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
› Verified 2 days ago
| NPI Number | 1497920227 |
| Organization Name | REHAB CARE |
| Address | 1414 N Prospect Ave, Milwaukee, WI 53202 |
| Phone Number | 414-277-8854 |
News Archive
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.
The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.
The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $8125 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 20.85 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.23 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.74 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.77 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 4.73 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0.62 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 4.37 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 86.59 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.37 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 85.41 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 28.81 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 17.47 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 1.67 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 97.03 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 61.43 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 69.3 | 82.93 |
News Archive
A new material developed at the University of Virginia - an oxygen nanosensor that couples a light-emitting dye with a biopolymer - simplifies the imaging of oxygen-deficient regions of tumors. Such tumors are associated with increased cancer aggressiveness and are particularly difficult to treat.
Researchers provide a guideline regarding who should be actually taking antimalarial drugs as prophylaxis to prevent getting COVID-19. They say health professionals who are being exposed to COVID-19 positive patients and those who test positive but are asymptomatic should be taking drugs such as Chloroquine and Hydroxychloroquine. They explain that these populations remain most in need, and because of limited supply, these individuals need to be prioritized.
The King Cobra continues to weave its charm with researchers identifying a protein in its venom with the potential for new drug discovery and to advance understanding of disease mechanisms.
"A global initiative to rid the world of polio launched an emergency action plan on Thursday because gaps in funding and vaccination coverage threaten to derail a final push towards stamping out the paralyzing disease," AlertNet reports.
› Verified 2 days ago
Eastcastle Pl Bradford Ter Conv Ctr Location: 2505 E Bradford Ave, Milwaukee, Wisconsin 53211 Phone: (414) 963-6151 | |
Jewish Home And Care Center Location: 1414 N Prospect Ave, Milwaukee, Wisconsin 53202 Phone: (414) 276-2627 | |
Villa At Bradley Estates (the) Location: 6735 W Bradley Rd, Milwaukee, Wisconsin 53223 Phone: (414) 354-3300 | |
Maple Ridge Health Services Location: 2730 W Ramsey Ave, Milwaukee, Wisconsin 53221 Phone: (414) 282-2600 | |